GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (MEX:IDXX) » Definitions » Cyclically Adjusted Price-to-FCF

IDEXX Laboratories (MEX:IDXX) Cyclically Adjusted Price-to-FCF : 79.93 (As of Jun. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is IDEXX Laboratories Cyclically Adjusted Price-to-FCF?

As of today (2025-06-02), IDEXX Laboratories's current share price is MXN10143.40. IDEXX Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was MXN126.91. IDEXX Laboratories's Cyclically Adjusted Price-to-FCF for today is 79.93.

The historical rank and industry rank for IDEXX Laboratories's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MEX:IDXX' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 57.7   Med: 104.89   Max: 212.8
Current: 82.37

During the past years, IDEXX Laboratories's highest Cyclically Adjusted Price-to-FCF was 212.80. The lowest was 57.70. And the median was 104.89.

MEX:IDXX's Cyclically Adjusted Price-to-FCF is ranked worse than
81.82% of 66 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.69 vs MEX:IDXX: 82.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

IDEXX Laboratories's adjusted free cash flow per share data for the three months ended in Mar. 2025 was MXN51.927. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is MXN126.91 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


IDEXX Laboratories Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for IDEXX Laboratories's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Cyclically Adjusted Price-to-FCF Chart

IDEXX Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 176.12 182.37 99.18 111.70 70.70

IDEXX Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.19 89.65 90.46 70.70 67.38

Competitive Comparison of IDEXX Laboratories's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, IDEXX Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Cyclically Adjusted Price-to-FCF falls into.


;
;

IDEXX Laboratories Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

IDEXX Laboratories's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=10143.40/126.91
=79.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, IDEXX Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=51.927/134.9266*134.9266
=51.927

Current CPI (Mar. 2025) = 134.9266.

IDEXX Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 9.369 100.684 12.555
201509 10.241 100.392 13.764
201512 11.973 99.792 16.188
201603 0.963 100.470 1.293
201606 19.329 101.688 25.647
201609 18.718 101.861 24.794
201612 19.541 101.863 25.884
201703 1.596 102.862 2.094
201706 19.161 103.349 25.015
201709 19.226 104.136 24.911
201712 21.855 104.011 28.351
201803 2.282 105.290 2.924
201806 20.222 106.317 25.664
201809 16.705 106.507 21.163
201812 21.420 105.998 27.266
201903 -0.848 107.251 -1.067
201906 22.652 108.070 28.281
201909 21.380 108.329 26.629
201912 23.665 108.420 29.451
202003 -5.895 108.902 -7.304
202006 49.045 108.767 60.841
202009 44.252 109.815 54.371
202012 46.823 109.897 57.487
202103 24.519 111.754 29.603
202106 48.556 114.631 57.153
202109 33.795 115.734 39.399
202112 42.426 117.630 48.665
202203 16.957 121.301 18.862
202206 8.479 125.017 9.151
202209 36.186 125.227 38.989
202212 28.886 125.222 31.125
202303 31.001 127.348 32.846
202306 35.284 128.729 36.983
202309 49.428 129.860 51.357
202312 43.940 129.419 45.810
202403 33.271 131.776 34.066
202406 47.234 132.554 48.080
202409 45.516 133.029 46.165
202412 56.281 133.157 57.029
202503 51.927 134.927 51.927

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IDEXX Laboratories  (MEX:IDXX) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


IDEXX Laboratories Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories Business Description

Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.